S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CELZ Creative Medical Technology Holdings Inc

2.45

0.0292 (1.21%)

Pre Market

Last Updated: 00:14:42

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

null

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technology Holdings Inc News

Form 8-K - Current report
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 24 October 2024 (3 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Wednesday 23 October 2024 (3 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 10 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 26 July 2024 (6 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
Wednesday 24 July 2024 (6 months ago) • GlobeNewswire Inc.

More Creative Medical Technology Holdings Inc News Articles

Australia And New Zealan...

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions